Bexarotene tabbed for localized CTCL

Article

New Orleans - Bexarotene gel (Targretin) appears to be both effective and well tolerated for long-term use in early-stage cutaneous T-cell lymphoma, according to a poster presentation at the American Academy of Dermatology annual meeting.

Related Videos
Related Content

Stefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology Network

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

Stefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology Network

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

Stefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology Network

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.